NEW YORK, July 22, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, announces that a shareholder filed a class action on behalf of purchasers of common stock of Neogen Corporation (NASDAQ: NEOG) between January 5, 2023 and June 3, 2025. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than September 16, 2025. SO WHAT: If you purchased Neogen common stock during the Class Period you may be entitled to comp ...

LOS ANGELES, July 22, 2025 /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Neogen Corporation ("Neogen" or "the Company") (NASDAQ: NEOG) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.Investors who purchased the Company's securities between January 5, 2023 and June 3, 2025, inclusive (the "Class Period"), are ...

Core Viewpoint - Neogen Corporation is facing a class action lawsuit due to alleged violations of the Securities Exchange Act of 1934, with claims that the company and its executives misled investors regarding the integration of its business with 3M's Food Safety Division [1][3]. Company Overview - Neogen Corporation engages in the development, manufacture, and marketing of products and services focused on food and animal safety [2]. Class Action Details - The class action lawsuit is titled "Operating Engineers Construction Industry and Miscellaneous Pension Fund v. Neogen Corporation" and allows investors who purchased Neogen common stock between January 5, 2023, and June 3, 2025, to seek appointment as lead plaintiff by September 16, 2025 [1][7]. Allegations Against Neogen - The lawsuit alleges that Neogen's executives made false statements about the progress of the integration with 3M, leading investors to believe it was going well, while downplaying inefficiencies that arose during the process [3][4]. - On January 10, 2025, Neogen reported a significant GAAP net income loss due to a $461 million non-cash goodwill impairment charge related to the 3M acquisition, leading to a stock price drop of over 5% [4]. - On April 9, 2025, Neogen announced a loss of $11 million for the third quarter of 2025, a significant increase from a $2 million loss the previous year, and reported a 3.4% revenue decline to $221 million, resulting in a 28% drop in stock price [5]. - On June 4, 2025, Neogen projected a drop in EBITDA margin to the high teens from 22%, attributing this to elevated inventory write-offs, which caused the stock price to fall more than 17% [6]. Legal Process - The Private Securities Litigation Reform Act of 1995 allows any investor who purchased Neogen common stock during the class period to seek appointment as lead plaintiff, representing the interests of the class [7]. Law Firm Background - Robbins Geller Rudman & Dowd LLP is a leading law firm in securities fraud and shareholder litigation, having recovered over $2.5 billion for investors in 2024 alone [8][9].

Core Viewpoint - A class action lawsuit has been filed against Neogen Corporation for allegedly misrepresenting the status of its integration with 3M and failing to disclose the negative impacts on its financial health during the Class Period from January 5, 2023, to June 3, 2025 [1][3]. Financial Performance and Impact - Neogen reported a significant GAAP net income loss in Q2 2025, including a $461 million non-cash goodwill impairment charge related to the 3M acquisition, leading to a 5% decline in stock price to $12.36 per share [4]. - In Q1 2025, Neogen's revenue fell by 3.4% to $221 million due to integration issues, resulting in a 28% drop in stock price to $5.02 per share after cutting FY25 guidance and announcing CEO Adent's resignation [5]. - On June 4, 2025, Neogen projected an EBITDA margin in the high teens, a significant decrease from the previous quarter's 22%, causing an additional 17% drop in stock price to $4.96 per share [6]. Legal Proceedings - Investors who acquired Neogen shares during the Class Period are encouraged to contact Bragar Eagel & Squire, P.C. to discuss their legal rights and options [1][7]. - The deadline for investors to apply to be appointed as lead plaintiff in the lawsuit is September 16, 2025 [1]. Company Background - Neogen Corporation is publicly traded on NASDAQ under the ticker NEOG and has faced scrutiny regarding its financial disclosures and integration processes with 3M [1][3].

SAN DIEGO, July 21, 2025 (GLOBE NEWSWIRE) -- Robbins LLP reminds stockholders that a class action was filed on behalf of investors who purchased or otherwise acquired Neogen Corporation (NASDAQ: NEOG) securities between January 6, 2023 and June 3, 2025. Neogen is a food safety company that manufactures and markets products and services dedicated to food and animal safety. For more information, submit a form, email attorney Aaron Dumas, Jr., or give us a call at (800) 350-6003. The Allegations: Robbins LLP i ...

Group 1 - A securities class action lawsuit has been filed against Neogen Corporation for misleading statements made during the integration process from January 5, 2023, to June 3, 2025 [1][2] - The complaint alleges that Neogen's management falsely claimed that the integration was progressing well, despite acknowledging certain inefficiencies [2] - Investors are encouraged to contact the law firm before the lead plaintiff motion deadline on September 16, 2025, to discuss their rights [3]

NEW YORK, July 21, 2025 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP announces that a shareholder has filed a securities class action lawsuit on behalf of investors (the “Class”) who purchased or acquired the common stock of Neogen Corporation (“Neogen” or the “Company”) (NASDAQ: NEOG) between January 5, 2023 and June 3, 2025, inclusive. For more information, submit a form at Neogen Corporation Shareholder Class Action Lawsuit, email Investor Relations Manager Peter Allocco at pallocco@bernlieb.com, or call u ...

Core Viewpoint - Neogen Corporation is facing a class action lawsuit due to alleged violations of the Securities Exchange Act of 1934, with claims that the company and its executives misled investors regarding the integration of its business with 3M's Food Safety Division and the financial implications of this merger [1][3][4]. Group 1: Class Action Details - The class action lawsuit is titled "Operating Engineers Construction Industry and Miscellaneous Pension Fund v. Neogen Corporation" and covers purchasers of Neogen common stock from January 5, 2023, to June 3, 2025 [1]. - Investors have until September 16, 2025, to seek appointment as lead plaintiff in the lawsuit [1]. - The lawsuit alleges that Neogen's executives made false statements about the progress of the integration with 3M and downplayed inefficiencies that arose during this process [3]. Group 2: Financial Performance and Impact - On January 10, 2025, Neogen reported a significant GAAP net income loss due to a $461 million non-cash goodwill impairment charge related to the 3M acquisition, leading to a more than 5% drop in stock price [4]. - In the third quarter of 2025, Neogen reported a loss of $11 million, a significant increase from a loss of $2 million the previous year, and a revenue decline of 3.4% to $221 million, attributed to integration issues [5]. - Following the announcement of expected EBITDA margin drop to the high teens from 22%, Neogen's stock price fell more than 17% [6].

SAN DIEGO, July 18, 2025 /PRNewswire/ -- Robbins LLP informs stockholders that a class action was filed on behalf of investors who purchased or otherwise acquired Neogen Corporation (NASDAQ: NEOG) securities between January 6, 2023 and June 3, 2025. Neogen is a food safety company that manufactures and markets products and services dedicated to food and animal safety.For more information, submit a form, email attorney Aaron Dumas, Jr., or give us a call at (800) 350-6003.The Allegations: Robbins LLP is Inve ...

NEW YORK, June 28, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Neogen Corporation (“Neogen” or the “Company”) (NASDAQ: NEOG).   Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.    The investigation concerns whether Neogen and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.  [Click here for information about joining the class action] On June 4, ...